Valerio De Stefano Selected Research

Multiple Myeloma

12/2023	Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
11/2022	Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel.
10/2022	Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
10/2022	Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma.
10/2022	Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.
3/2022	Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
1/2022	Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
1/2022	LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma.
2/2021	Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.
1/2021	Progression to Symptomatic Multiple Myeloma Predicted by Texture Analysis-Derived Parameters in Patients Without Focal Disease at 18F-FDG PET/CT.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valerio De Stefano Research Topics

Disease

40	Thrombosis (Thrombus) 07/2023 - 12/2002
21	Thrombophilia 01/2021 - 05/2002
20	Polycythemia Vera 03/2024 - 10/2002
20	Neoplasms (Cancer) 03/2024 - 06/2008
18	Multiple Myeloma 12/2023 - 03/2006
18	Venous Thromboembolism 10/2022 - 05/2002
16	Hemorrhage 01/2021 - 10/2004
14	Essential Thrombocythemia 03/2024 - 10/2002
14	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 12/2002
10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2024 - 03/2007
10	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 02/2014
9	COVID-19 01/2023 - 10/2020
6	Infections 07/2023 - 10/2012
5	Splenomegaly 01/2023 - 02/2017
4	Clinical Deterioration 01/2018 - 12/2010
4	Budd-Chiari Syndrome (Budd Chiari Syndrome) 12/2014 - 09/2012
4	Hyperhomocysteinemia 12/2014 - 10/2002
3	Thrombocytosis (Thrombocythemia) 04/2022 - 10/2002
3	Myocardial Infarction 04/2020 - 09/2004
3	Fibrosis (Cirrhosis) 01/2018 - 11/2014
3	Protein S Deficiency (Deficiency, Protein S) 03/2013 - 05/2002
2	Lymphoma (Lymphomas) 07/2023 - 01/2022
2	Thromboembolism 10/2022 - 03/2006
2	Ischemic Stroke 10/2022 - 01/2018
2	Leukemia 06/2022 - 01/2017
2	Thrombocytopenia (Thrombopenia) 12/2021 - 01/2021
2	Atrial Fibrillation 10/2021 - 10/2004
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2021 - 12/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019 - 01/2015
2	Stroke (Strokes) 11/2018 - 03/2014
2	Pulmonary Embolism 01/2018 - 02/2015
2	Liver Diseases (Liver Disease) 01/2018 - 06/2015
2	Multiple Abnormalities 10/2013 - 06/2008
2	Wounds and Injuries (Trauma) 10/2012 - 01/2003
2	Upper Extremity Deep Vein Thrombosis 09/2012 - 06/2010
2	Acute Coronary Syndrome 03/2008 - 09/2004
1	Vasculitis (Vasculitides) 07/2023
1	Cryoglobulinemia 07/2023

Drug/Important Bio-Agent (IBA)

20	AnticoagulantsIBA 01/2022 - 10/2004
15	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2023 - 05/2012
15	ruxolitinibIBA 10/2023 - 02/2014
15	Prothrombin (Factor II)IBA 11/2014 - 05/2002
14	factor V LeidenIBA 10/2013 - 05/2002
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2007
10	Protein CIBA 12/2013 - 05/2002
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 04/2010
9	Vitamin K FDA Link 01/2022 - 03/2008
8	AntithrombinsIBA 10/2013 - 05/2002
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021 - 10/2004
7	Protein SIBA 04/2014 - 10/2002
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2009
6	Oral ContraceptivesIBA 10/2012 - 01/2003
5	Inosine Triphosphate (ITP)IBA 01/2023 - 04/2010
5	Lenalidomide (CC 5013)FDA Link 10/2022 - 06/2012
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 02/2003
4	elotuzumabIBA 10/2022 - 01/2021
3	InterferonsIBA 03/2024 - 09/2021
3	Prednisone (Sone)FDA LinkGeneric 01/2024 - 03/2006
3	fibrin fragment D (D-dimer)IBA 01/2023 - 03/2016
3	Proteasome InhibitorsIBA 11/2022 - 05/2020
3	daratumumabIBA 10/2022 - 05/2020
3	Hemostatics (Antihemorrhagics)IBA 12/2021 - 11/2009
3	VaccinesIBA 12/2021 - 09/2021
3	Bortezomib (Velcade)FDA Link 01/2021 - 07/2012
3	Thrombopoietin ReceptorsIBA 01/2021 - 06/2015
3	Rituximab (Mabthera)FDA Link 01/2020 - 03/2007
3	Proteins (Proteins, Gene)FDA Link 02/2015 - 10/2012
3	Antiphospholipid AntibodiesIBA 01/2015 - 06/2008
2	Immunoglobulin G (IgG)IBA 07/2023 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 07/2023 - 01/2020
2	Fibrinogen (Factor I)FDA Link 01/2023 - 04/2014
2	Monoclonal AntibodiesIBA 11/2022 - 01/2022
2	Immunomodulating AgentsIBA 11/2022 - 01/2022
2	C-Reactive ProteinIBA 04/2022 - 10/2021
2	carfilzomibIBA 03/2022 - 01/2022
2	mRNA VaccinesIBA 01/2022 - 09/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 03/2008
2	COVID-19 VaccinesIBA 01/2021 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 03/2016
2	Factor V (Coagulation Factor V)IBA 11/2014 - 10/2012
2	Thalidomide (Thalomid)FDA Link 07/2012 - 03/2006
2	Enoxaparin (Lovenox)FDA LinkGeneric 03/2006 - 10/2004
1	Interferon alpha-2 (Roferon-A)FDA Link 03/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 07/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2023
1	CryoglobulinsIBA 07/2023
1	Rheumatoid FactorIBA 07/2023
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2023

Therapy/Procedure

29	Therapeutics 03/2024 - 12/2002
7	Drug Therapy (Chemotherapy) 04/2022 - 03/2006
4	Hematopoietic Stem Cell Transplantation 01/2023 - 07/2012
4	Catheters 01/2016 - 06/2010
3	Salvage Therapy 03/2022 - 01/2021
3	Stem Cell Transplantation 01/2021 - 11/2016
2	Splenectomy 01/2021 - 02/2014
2	Liver Transplantation 01/2021 - 01/2018
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2016 - 12/2010